Set-back Suture Versus Traditional Vertical Mattress Suture
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01773447|
Recruitment Status : Completed
First Posted : January 23, 2013
Last Update Posted : March 31, 2017
|Condition or disease||Intervention/treatment||Phase|
|Basal Cell Carcinoma Squamous Cell Carcinoma Melanoma||Procedure: Set-back suture Procedure: Vertical mattress suture||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||47 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||Comparing Wound Eversion and Clinical Outcomes in Surgical Wound Repair With Subcuticular Set-back Versus Traditional Vertical Mattress Suturing Techniques|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||April 2014|
Active Comparator: Set-back suture
Wound to be close by set-back suture technique.
Procedure: Set-back suture
Active Comparator: Vertical mattress suture technique
Wound to be closed by vertical mattress technique.
Procedure: Vertical mattress suture
- Mean of sum of 2 blinded reviewers Physician Observer Assessment scores [ Time Frame: 3 months ]
Compare the functional and cosmetic outcomes of the two sutured halves of each scar at 3 months follow-up as follows:
a. Use a previously validated scar assessment scale called the Patient and Observer Scar Assessment Scale, specifically the averaged sum of the total score of 2 blinded observers.
- Scar width [ Time Frame: 3 months ]Width of scar in millimeters for each side of scar measured 1 cm from the midline.
- Height of scar immediately following wound closure [ Time Frame: 5 minutes ]Height of each side of the wound will be measured 1 cm from the midpoint of the wound in millimeters
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01773447
|United States, California|
|UC Davis, Department of Dermatology|
|Sacramento, California, United States, 95816|
|Principal Investigator:||Daniel Eisen, M.D.||University of California, Davis|